Cannabis Use and Heart Transplantation: Disparities and Opportunities to Improve Outcomes

Onyedika J. Ilonze; Denise C. Vidot; Khadijah Breathett; Marlene Camacho-Rivera; Subha V. Raman; Jon A. Kobashigawa; Larry A. Allen

doi:10.1161/CIRCHEARTFAILURE.122.009488

Cannabis Use and Heart Transplantation: Disparities and Opportunities to Improve Outcomes

Onyedika J. Ilonze, Denise C. Vidot, Khadijah Breathett, Marlene Camacho-Rivera, Subha V. Raman, Jon A. Kobashigawa, Larry A. Allen

Research output: Contribution to journal › Review article › peer-review

2 Scopus citations

Abstract

Heart transplantation (HT) remains the optimal therapy for many patients with advanced heart failure. Use of substances of potential abuse has historically been a contraindication to HT. Decriminalization of cannabis, increasing cannabis use, clinician biases, and lack of consensus for evaluating patients with heart failure who use cannabis all have the potential to exacerbate racial and ethnic and regional disparities in HT listing and organ allocation. Here‚ we review pertinent pre-HT and post-HT considerations related to cannabis use‚ and relative attitudes between opiates and cannabis are offered for context. We conclude with identifying unmet research needs pertaining to the use of cannabis in HT that can inform a standardized evaluation process.

Original language	English (US)
Pages (from-to)	E009488
Journal	Circulation: Heart Failure
Volume	15
Issue number	12
DOIs	https://doi.org/10.1161/CIRCHEARTFAILURE.122.009488
State	Published - Dec 1 2022
Externally published	Yes

Keywords

cannabis
contraindications
heart failure
heart transplantation
illicit drugs

ASJC Scopus subject areas

Cardiology and Cardiovascular Medicine

Access to Document

10.1161/CIRCHEARTFAILURE.122.009488

Cite this

@article{9082c475e8ee4dafb53b3c86f9beb1f5,

title = "Cannabis Use and Heart Transplantation: Disparities and Opportunities to Improve Outcomes",

abstract = "Heart transplantation (HT) remains the optimal therapy for many patients with advanced heart failure. Use of substances of potential abuse has historically been a contraindication to HT. Decriminalization of cannabis, increasing cannabis use, clinician biases, and lack of consensus for evaluating patients with heart failure who use cannabis all have the potential to exacerbate racial and ethnic and regional disparities in HT listing and organ allocation. Here‚ we review pertinent pre-HT and post-HT considerations related to cannabis use‚ and relative attitudes between opiates and cannabis are offered for context. We conclude with identifying unmet research needs pertaining to the use of cannabis in HT that can inform a standardized evaluation process.",

keywords = "cannabis, contraindications, heart failure, heart transplantation, illicit drugs",

author = "Ilonze, {Onyedika J.} and Vidot, {Denise C.} and Khadijah Breathett and Marlene Camacho-Rivera and Raman, {Subha V.} and Kobashigawa, {Jon A.} and Allen, {Larry A.}",

year = "2022",

month = dec,

day = "1",

doi = "10.1161/CIRCHEARTFAILURE.122.009488",

language = "English (US)",

volume = "15",

pages = "E009488",

journal = "Circulation: Heart Failure",

issn = "1941-3289",

publisher = "Lippincott Williams and Wilkins",

number = "12",

}

TY - JOUR

T1 - Cannabis Use and Heart Transplantation

T2 - Disparities and Opportunities to Improve Outcomes

AU - Ilonze, Onyedika J.

AU - Vidot, Denise C.

AU - Breathett, Khadijah

AU - Camacho-Rivera, Marlene

AU - Raman, Subha V.

AU - Kobashigawa, Jon A.

AU - Allen, Larry A.

PY - 2022/12/1

Y1 - 2022/12/1

N2 - Heart transplantation (HT) remains the optimal therapy for many patients with advanced heart failure. Use of substances of potential abuse has historically been a contraindication to HT. Decriminalization of cannabis, increasing cannabis use, clinician biases, and lack of consensus for evaluating patients with heart failure who use cannabis all have the potential to exacerbate racial and ethnic and regional disparities in HT listing and organ allocation. Here‚ we review pertinent pre-HT and post-HT considerations related to cannabis use‚ and relative attitudes between opiates and cannabis are offered for context. We conclude with identifying unmet research needs pertaining to the use of cannabis in HT that can inform a standardized evaluation process.

AB - Heart transplantation (HT) remains the optimal therapy for many patients with advanced heart failure. Use of substances of potential abuse has historically been a contraindication to HT. Decriminalization of cannabis, increasing cannabis use, clinician biases, and lack of consensus for evaluating patients with heart failure who use cannabis all have the potential to exacerbate racial and ethnic and regional disparities in HT listing and organ allocation. Here‚ we review pertinent pre-HT and post-HT considerations related to cannabis use‚ and relative attitudes between opiates and cannabis are offered for context. We conclude with identifying unmet research needs pertaining to the use of cannabis in HT that can inform a standardized evaluation process.

KW - cannabis

KW - contraindications

KW - heart failure

KW - heart transplantation

KW - illicit drugs

UR - http://www.scopus.com/inward/record.url?scp=85144113705&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85144113705&partnerID=8YFLogxK

U2 - 10.1161/CIRCHEARTFAILURE.122.009488

DO - 10.1161/CIRCHEARTFAILURE.122.009488

M3 - Review article

C2 - 36252094

AN - SCOPUS:85144113705

SN - 1941-3289

VL - 15

SP - E009488

JO - Circulation: Heart Failure

JF - Circulation: Heart Failure

IS - 12

ER -

Cannabis Use and Heart Transplantation: Disparities and Opportunities to Improve Outcomes

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this